HEALTH● ELEVATED1d ago · Oct 14, 2026, 8:07 AM
Cancer Drug Spending Is Headed Past $400 Billion as Colorectal and Pancreatic Cancers Move Up the Research Agenda
equity_insider · united states of america · global
Global cancer drug spending reached $252 billion in 2024 and is forecast to exceed $400 billion by 2028, with colorectal and pancreatic cancers gaining prominence on research agendas as companies including Oncolytics Biotech, Revolution Medicines, Eli Lilly, Genmab, and Exelixis advance targeted therapies and combinations.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
See it on the live mapunited states of america and nearby eventsMore from united states of americaLatest stories and threat level
More in Health
HEALTH23m agoPope Leo XIV has 'good night' in hospital after lung surgery, Vatican saysEuroNews [en]HEALTH41m agoWHO Urges Action On Lead Poisoning DangersChannels TVHEALTH44m agoPublic warned of poisonous mushrooms resembling edible varietiesJapan TodayHEALTH46m ago'Spain's hallmark in Vatican': The Spanish medical science behind Pope Francis' lung operationEuroNews [en]